Literature DB >> 22386553

Pharmacologic management of myxomatous mitral valve disease in dogs.

Clarke E Atkins1, Jens Häggström.   

Abstract

Myxomatous mitral valve disease (MMVD) causing mitral regurgitation is the most important disease of the heart in small animal cardiovascular medicine. Because MMVD is an example of a chronic disease that progresses from mild to severe over years, treatment strategies change with the stage of the disease. In this review the treatment options are compared and contrasted as they are discussed relative to the recently published ACVIM consensus statement regarding the treatment of MMVD. Results from clinical trials and evidence-based medicine are likely to provide significant improvements in the management of MMVD in the coming decades. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22386553     DOI： 10.1016/j.jvc.2012.02.002

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN： 1760-2734            Impact factor:   1.701


  15 in total

1.  Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.

Authors:  V Chetboul; J-L Pouchelon; J Menard; J Blanc; L Desquilbet; A Petit; S Rougier; L Lucats; F Woehrle
Journal:  J Vet Intern Med       Date:  2017-10-04       Impact factor: 3.333

2.  Sildenafil improves heart rate variability in dogs with asymptomatic myxomatous mitral valve degeneration.

Authors:  Prapawadee Pirintr; Nakkawee Saengklub; Vudhiporn Limprasutr; Suwanakiet Sawangkoon; Anusak Kijtawornrat
Journal:  J Vet Med Sci       Date:  2017-07-17       Impact factor: 1.267

3.  Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism.

Authors:  Kathryn M Meurs; Joshua A Stern; Clarke E Atkins; Darcy Adin; Brent Aona; Julia Condit; Teresa DeFrancesco; Yamir Reina-Doreste; Bruce W Keene; Sandy Tou; Jessica Ward; Kathleen Woodruff
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Oct-Dec       Impact factor: 1.636

4.  Long-term effect of sildenafil on echocardiographic parameters in dogs with asymptomatic myxomatous mitral valve degeneration.

Authors:  Anusak Kijtawornrat; Siripen Komolvanich; Nakkawee Saengklub; Prapawadee Pirintr; Pakit Boonpala; Chollada Buranakarl
Journal:  J Vet Med Sci       Date:  2017-03-11       Impact factor: 1.267

5.  Real-Time 3-Dimensional Echocardiographic Assessment of Effective Regurgitant Orifice Area in Dogs With Myxomatous Mitral Valve Disease.

Authors:  A Tidholm; A Bodegård-Westling; K Höglund; J Häggström; I Ljungvall
Journal:  J Vet Intern Med       Date:  2017-01-21       Impact factor: 3.333

6.  Effect of a lactate-guided conditioning program on heart rate variability obtained using 24-Holter electrocardiography in Beagle dogs.

Authors:  Alejandro Z Restan; Aparecido A Camacho; Juliana A Cerqueira; Evandro Zacché; Murillo D Kirnew; Bruna A Loureiro; Samara B Silva; Henriette G Moranza; Guilherme C Ferraz
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

7.  Comparison between real-time 3-dimensional and 2-dimensional biplane echocardiographic assessment of left atrial volumes in dogs with myxomatous mitral valve disease.

Authors:  Anna Tidholm; Anna Bodegård-Westling; Katja Höglund; Jens Häggström; Ingrid Ljungvall
Journal:  J Vet Intern Med       Date:  2019-01-09       Impact factor: 3.333

8.  Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement.

Authors:  J L Pouchelon; C E Atkins; C Bussadori; M A Oyama; S L Vaden; J D Bonagura; V Chetboul; L D Cowgill; J Elliot; T Francey; G F Grauer; V Luis Fuentes; N Sydney Moise; D J Polzin; A M Van Dongen; N Van Israël
Journal:  J Small Anim Pract       Date:  2015-09       Impact factor: 1.522

9.  Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease.

Authors:  A Tidholm; K Höglund; J Häggström; I Ljungvall
Journal:  J Vet Intern Med       Date:  2015-09-14       Impact factor: 3.333

10.  Acute effect of ivabradine on heart rate and myocardial oxygen consumption in dogs with asymptomatic mitral valve degeneration.

Authors:  Prapawadee Pirintr; Vudhiporn Limprasutr; Nakkawee Saengklub; Parnpradub Pavinadol; Napat Yapao; Natthakarn Limvanicharat; Hathaisiri Kuecharoen; Anusak Kijtawornrat
Journal:  Exp Anim       Date:  2018-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.